[27I-pm] がん

Fri. Mar 27, 2020 3:33 PM - 5:09 PM [Room I] Room I (2F)

Chair: Tomomi Furihata, Yukio Suga

+Add all to schedule

3:33 PM - 3:45 PM

[27I-pm09] DJ-1 regulates stem cell self-renewal of U87 glioblastoma cells

○Yuki Toda¹, Ryosuke Yoshimura¹, Masao Itahara¹, Tomoko Uno¹, Susumu Nakata¹, Kanae Yamada¹, Yuri Imai¹, Kazuyuki Takata¹, Eishi Ashihara¹ (1. Kyoto Pharm. Univ.)

3:45 PM - 3:57 PM

[27I-pm10S] Stat5b promotes glioblastoma stem cell proliferation and survival derived from a glioblastoma mouse model

○Chiami Moyama¹, Mitsugu Fujita², Shota Ando¹, Keiko Taniguchi¹, Hiromi Ii¹, Susumu Nakata¹ (1. Kyoto Pharm Univ., 2. Faculty of Med., Kindai Univ.)

3:57 PM - 4:09 PM

[27I-pm11S] The functional analysis of α₁-acid glycoprotein increased in cancer pathology

○Kotaro Matsusaka¹, Yukio Fujiwara², Hitoshi Maeda¹, Hiroshi Watanabe¹, Yoshihiro Komohara², Toru Maruyama¹ (1. Grad. Sch. Pharm. Sci., Kumamoto Univ., 2. Grad. Sch. Med. Sci., Kumamoto Univ.)

4:09 PM - 4:21 PM

[27I-pm12S] Development of novel conditionally replicating adenoviruses for efficient detection of circulating tumor cells

○Sena Ikemoto¹, Fuminori Sakurai^1,2, Kousuke Takayama², Takahiro Okabe⁶, Shinsaku Togo⁷, Hiroyuki Mizuguchi^1,2,3,4,5 (1. Sch.Pharm.Osaka Univ, 2. Grad.Sch.Pharm.Osaka Univ, 3. Ctr MEI,Osaka Univ, 4. NIBIOHN, 5. OTRI, Osaka Univ, 6. Leading Center for the development and research of cancer medicine, 7. Sch.Med.Juntendo Univ)

4:21 PM - 4:33 PM

[27I-pm13S] Isolation and characterization of a novel osteoclast differentiation factor from high bone metastatic lung cancer cell line

○Sato Masaru¹, Momo Jurina¹, Tokida Yuri¹, Iwasaki Hikaru¹, Ohta Tomoyuki¹, Matsumoto Mitsunobu², Tatano Yutaka¹, Yagi Hideki¹ (1. Dept. Pharm. Sci., Sch. Pharm., IUHW, 2. Shionogi Co. Ltd.)

4:33 PM - 4:45 PM

[27I-pm14] GTP metabolic reprogramming regulates nucleolar activity in the brain tumor

○Satoshi Kofuji¹, Atsuo Sasaki^2,3 (1. Med. Res. Inst., Tokyo Med Den Univ. , 2. Col. Med., Univ. Cincinnati, 3. Inst. Adv. Biosci., Keio Univ.)

4:45 PM - 4:57 PM

[27I-pm15] FROUNT inhibitor disulfiram as a new class of macrophage-targeting anti-cancer drug

○Yuya Terashima¹, Toda Etsuko², Kouji Matsushima¹ (1. Res. Ins. Bio. Sci., Tokyo Univ. Sci., 2. Dep. Ana. Hum. Path., Nippon Med. Sch.)

4:57 PM - 5:09 PM

[27I-pm16] A pilot study of searching for epigenetic abnormalities in blood of cancer patients

○Toshiki Aiba¹, Goro Kasuya¹, Makoto Shinoto¹, Toshiyuki Saito¹, Shizuko Kakinuma¹ (1. Quantum Medical Science Directorate,QST)

Session information